STOKE THERAPEUTICS, INC.

Profile

Company Names

STOKE THERAPEUTICS, INC.
ASOTHERA PHARMACEUTICALS, INC.

Addresses

3 PRESTON COURT, BEDFORD, MA 01730

ONE BUNGTOWN ROAD, COLD SPRING HARBOR, NY 11724

Phone Numbers

(781) 430-8200
516.367.8831

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$90,850,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-10-22 
$90,000,000.00 
$90,000,000.00 
$0.00 
Equity 
1
2014-11-13 
$850,000.00 
$850,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
R. 
ALLERSON 
EXECUTIVE OFFICER
STOKE THERAPEUTICS, INC.
ISABEL 
 
AZNAREZ 
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
ASOTHERA PHARMACEUTICALS, INC.   |  STOKE THERAPEUTICS, INC.
SAMUEL 
W. 
HALL 
DIRECTOR
STOKE THERAPEUTICS, INC.   |  PETRICHOR SCION THERAPEUTICS LLC
SETH 
L. 
HARRISON 
DIRECTOR
TOKAI PHARMACEUTICALS INC   |  APPLE TREE PARTNERS II - ANNEX, L.P.   |  AILERON THERAPEUTICS INC   |  STOKE THERAPEUTICS, INC.   |  LIMELIGHT BIO, INC.
EDWARD 
M. 
KAYE 
EXECUTIVE OFFICER, DIRECTOR
STOKE THERAPEUTICS, INC.
ADRIAN 
 
KRAINER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ASOTHERA PHARMACEUTICALS, INC.   |  STOKE THERAPEUTICS, INC.
ARTHUR 
A. 
LEVIN 
DIRECTOR
STOKE THERAPEUTICS, INC.
GENE 
 
LIAU 
EXECUTIVE OFFICER
STOKE THERAPEUTICS, INC.
MEENA 
 
MEENA 
EXECUTIVE OFFICER
STOKE THERAPEUTICS, INC.
HUW 
 
NASH 
EXECUTIVE OFFICER
ASOTHERA PHARMACEUTICALS, INC.
HUW 
M. 
NASH 
EXECUTIVE OFFICER
STOKE THERAPEUTICS, INC.
BARRY 
 
TICHO 
EXECUTIVE OFFICER
STOKE THERAPEUTICS, INC.
ARTHUR 
 
TZIANABOS 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  HOMOLOGY MEDICINES, INC.   |  AKOUOS, INC.   |  STOKE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-22 
2014-11-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-11-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#